2024 | A population pharmacokinetic model of methotrexate in Korean patients with haematologic malignancy | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
2024 | Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria
| PHARMACEUTICS |
2023 | Model-informed precision dosing in vancomycin treatment
| FRONTIERS IN PHARMACOLOGY |
2023 | Development of a population pharmacokinetic model and optimal dosing regimen of leflunomide in Korean population
| EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES |
2022 | Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers
| DRUG DESIGN DEVELOPMENT AND THERAPY |
2022 | A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer
| PHARMACEUTICS |
2022 | The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities
| CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY |
2021 | Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers
| JOURNAL OF PERSONALIZED MEDICINE |
2021 | Predicting the longitudinal changes of levodopa dose requirements in Parkinson's disease using item response theory assessment of real-world Unified Parkinson's Disease Rating Scale
| CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY |
2021 | Population Pharmacokinetics of Primaquine in the Korean Population
| PHARMACEUTICS |
2021 | Development of a risk scoring system for predicting acute kidney injury after minimally invasive partial and radical nephrectomy: a retrospective study | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
2020 | Chemical Controllable Gene Drive in Drosophila | ACS SYNTHETIC BIOLOGY |
2020 | Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects
| MOLECULAR GENETICS & GENOMIC MEDICINE |
2020 | Dynamic predictive model for postoperative nausea and vomiting for intravenous fentanyl patient-controlled analgesia | ANAESTHESIA |
2019 | Predicting Disease Progression in Patients with Bicuspid Aortic Stenosis Using Mathematical Modeling
| Journal of Clinical Medicine |
2019 | Optimal Dosing Regimen of Phenytoin for Korean Epilepsy Patients: From Premature Babies to the Elderly | Journal of Pharmaceutical Sciences |
2018 | Population pharmacokinetic model of levetiracetam in Korean neonates with seizures | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS |
2018 | Population PK-PD Model of Pegylated Interferon Alfa-2a in Healthy Korean Men | JOURNAL OF PHARMACEUTICAL SCIENCES |
2018 | Model-based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic stroke | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
2018 | A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy | AAPS JOURNAL |
2018 | An item response theory based integrated model of headache, nausea, photophobia, and phonophobia in migraine patients | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS |
2018 | Mechanistic Model for Blood Pressure and Heart Rate Changes Produced by Telmisartan in Human Beings | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
2017 | Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures
| Korean Journal of Pediatrics |
2017 | A Review of Modeling Approaches to Predict Drug Response in Clinical Oncology
| YONSEI MEDICAL JOURNAL |
2017 | Quantitative Assessment of Food Effect on the Pharmacokinetics of Nano-Crystallized Megestrol Acetate | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
2016 | Quantitative model for the blood pressure-lowering interaction of valsartan and amlodipine | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
2016 | Pore dilatation increases the bicarbonate permeability of CFTR, ANO1 and glycine receptor anion channels. | JOURNAL OF PHYSIOLOGY-LONDON |
2016 | Modelling of the Effect of End-Tidal Carbon Dioxide on Cerebral Oxygen Saturation in Beach Chair Position under General Anaesthesia. | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
2015 | Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS |
2014 | Population pharmacokinetic analysis of diurnal and seasonal variations of plasma concentrations of cilostazol in healthy volunteers.
| THERAPEUTIC DRUG MONITORING |
2014 | Pharmacokinetic Interaction Between Rosuvastatin and Metformin in Healthy Korean Male Volunteers: A Randomized, Open-label, 3-period, Crossover, Multiple-dose Study | CLINICAL THERAPEUTICS |
2014 | Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan: A Randomized, Open-label, 3-period, Multiple-dose Crossover Study in Healthy Korean Male Subjects | CLINICAL THERAPEUTICS |
2014 | Pharmacokinetic Interaction between Rosuvastatin and Telmisartan in Healthy Korean Male Volunteers: A Randomized, Open-label, Two-period, Crossover, Multiple-dose Study | CLINICAL THERAPEUTICS |
2014 | Development of a Pharmacokinetic Interaction Model for Co-administration of Simvastatin and Amlodipine
| DRUG METABOLISM AND PHARMACOKINETICS |
2013 | Pharmacokinetic Comparison of 2 Fixed-Dose Combination Tablets of Amlodipine and Valsartan in Healthy Male Korean Volunteers: A Randomized, Open-Label, 2-Period, Single-Dose, Crossover Study | CLINICAL THERAPEUTICS |
2013 | Pharmacokinetics of Rosuvastatin/Olmesartan Fixed-Dose Combination: A Single-Dose, Randomized, Open-Label, 2-Period Crossover Study in Healthy Korean Subjects | CLINICAL THERAPEUTICS |
2013 | Pharmacokinetic Comparison of an Orally Disintegrating Film Formulation With a Film-Coated Tablet Formulation of Sildenafil in Healthy Korean Subjects: A Randomized, Open-Label, Single-Dose, 2-Period Crossover Study | CLINICAL THERAPEUTICS |
2012 | The UGT1A3*2 polymorphism affects atorvastatin lactonization and lipid-lowering effect in healthy volunteers | PHARMACOGENETICS AND GENOMICS |
2012 | A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy | INVESTIGATIONAL NEW DRUGS |
2012 | Modeling of the LDL cholesterol-lowering effect of atorvastatin in Korean dyslipidemic patients and non-patient volunteers | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS |
2012 | The views of patients and healthy volunteers on participation in clinical trials: an exploratory survey study | CONTEMPORARY CLINICAL TRIALS |
2012 | Role of heat shock protein 47 in transdifferentiation of human tenon's fibroblasts to myofibroblasts
| BMC OPHTHALMOLOGY |
2011 | Pharmacokinetic comparison of sustained- and immediate-release oral formulations of cilostazol in healthy Korean subjects: a randomized, open-label, 3-part, sequential, 2-period, crossover, single-dose, food-effect, and multiple-dose study | CLINICAL THERAPEUTICS |
2011 | The T2-shortening effect of gadolinium and the optimal conditions for maximizing the CNR for evaluating the biliary system: a phantom study.
| KOREAN JOURNAL OF RADIOLOGY |
2011 | Population pharmacokinetics of amikacin in a Korean clinical population | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS |
2011 | The effect of beta1-adrenergic receptor gene polymorphism on prolongation of corrected QT interval during endotracheal intubation under sevoflurane anesthesia
| KOREAN JOURNAL OF ANESTHESIOLOGY |
2011 | Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants | CLINICAL PHARMACOLOGY & THERAPEUTICS |
2011 | Effect of CYP2B6 genotype on the pharmacokinetics of sibutramine and active metabolites in healthy subjects | JOURNAL OF CLINICAL PHARMACOLOGY |
2010 | PEG-인터페론 알파-2a 제제 DA-3021의 안전성 및 약동력학적 특성 연구
| Journal of Korean Society for Clinical Pharmacology and Therapeutics (임상약리학회지) |
2010 | Prognostic factors in small cell lung cancer: a new prognostic index in Korean patients | ONCOLOGY |